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ABSTRACT: Cell secretion was studied using secretory
granules and plasma membrane isolated for the pancreas. The 
exocytotic step in secretion is thought to involve the 
activation of electrolyte transport and the fusion of 
secretory membranes. The results showed that mastoparan, an 
amphiphilic peptide present in wasp venom, stimulated fusion 
between pancreatic zymogen granules and plasma membrane in 
the presence of guanosine triphosphate (GTP). This 
observation provides further evidence for the hypothesis 
that mastoparan acts by directly stimulating guanine 
nucleotide binding proteins (G-protein). In addition the 
results suggest that G-proteins are present on the zymogen 
granule membrane and provide control for exocytosis.
Mastoparan, in high concentrations, caused non-specific 
lysis of the zymogen granules and did not cause any direct 
change in the rate of Cl” transport. This inability to 
influence electrolyte transport across the granule membrane 
demonstrates that an endogenous G-protein for the regulation 
of ion channels is not associated with the secretory 
vesicle. Mastoparan's ability to permeate membranes and 
activate fusion-associated G-proteins, similar to a receptor 
coupled reaction, makes it an important pharmacological tool 
in exocytosis and secretion research.
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Introduction
Exocytosis is a process by which animal tissues release 
products such as hormones or enzymes into their surroundings. Prior 
to their release these substances are stored in intracellular 
secretory vesicles. During exocytosis these vesicles fuse with the 
plasma membrane and release their contents into the extracellular 
space. This important event is controlled and regulated by an 
integration of physiological and biochemical factors.
Exocytosis, like many other cellular activities occurs in 
response to an external stimulus. The external stimulus may be a 
hormone and is termed as the first messenger. It sets off a cascade 
of events which lead to exocytosis and secretion. These first 
messengers bind to receptors on the cell surface. The receptors 
transmit this information to the cell interior causing the 
production of intracellular regulatory molecules in the cytosol of 
the cell. These intracellular regulatory molecules are termed the 
second messengers. Four major kinds of second messengers are known, 
Ca2+, adenosine-3 *-5'-cyclic monophosphate(cAMP), diacyl glycerol 
(DAG) and inositol triphosphate (IP3) . These second messengers act 
by regulating the activities of enzymes. Common enzymatic effectors 
are the kinases which catalyze the phosphorylation of various 
proteins present inside the cell and thus control cell 
responsiveness. cAMP is formed from the conversion of ATP by an 
enzyme called adenylate cyclase. The pathway by which the signal 
reaches the adenylate cyclase is by the means of a transducer G- 
protein associated with the receptor. The action of the first 
messenger on the extracellular receptor causes the receptor to
catalyze the binding of the G-protein to GTP, this causes the G- 
protein to disassociate from the receptor leaving it free to 
activate the adenylate cyclase. This process continues until the 
GTP is hydrolyzed to GDP and the G-protein reassociates with 
receptor. The cAMP can bind enzymes called protein kinases which 
phosphorylate cellular proteins, altering their conformation and 
catalytic ability. Another cellular cascade of events involves the 
breakdown of a membrane phospholipid, phosphatidylinositol 4,5- 
biphosphate (PIP2) r into IP3 and DAG by phospholipase C. IP3 being 
water soluble diffuses into the cytosol and causes the release of 
calcium from intracellular stores. Ca2+ and DAG are necessary to 
activate protein kinase C. Exocytosis is probably controlled by 
both these pathways, although specific information about the 
control of exocytosis is not available. An important question is 
which G-protein controls exocytosis and whether they are present on 
the plasma membrane or the secretory vesicle membrane. Two post G- 
protein pathways have been suggested for the control of exocytosis, 
one in which phospholipase C (PLC) is activated and the other 
involves the activation of phospholipase A2. This enzyme removes
the fatty acid from the Sn-2 position of a phospholipid and 
modifies the fluidity of the membrane. Another mechanism recently 
suggested by Gomperts (1990) involves the presence of a G-protein 
Ge which is probably present in the vesicle membrane and controls 
the whole process of exocytosis by an unknown route.
The objective of this project is to study some of the 
biochemical and physiological factors that control this important
cellular event. Specifically we will study the rate of Cl”
transport across the vesicle membrane and the fusion of vesicle 
membrane to apical plasma membrane. In this project we will use 
mastoparan as an agent to study exocytotic secretion. Mastoparan is 
the active agent present in wasp venom and like other venoms it 
works by amplifying certain biochemical reactions in a cell. 
Mastoparan causes a large scale increase in exocytotic secretion in 
a wide variety of cells including mast, pituitary and pancreas 
(Gill et al., 1991). This particular feature makes it a useful 
agent for studying the mechanism of exocytotic secretion. We will 
try to identify which part of the exocytotic apparatus mastoparan 
affects by monitoring the rate of Cl" transport across vesicle 
membrane and the fusion of vesicle membrane to apical membrane. 
These two events are associated with the terminal steps in 
exocytosis and provide a sensitive physiological signal for the 
proj ect.
This study is different from other studies conducted on 
mastoparan1s effects on cellular secretion, in that it focuses its 
attention on individual secretory vesicles and not the whole cell. 
This will give a more clear understanding of what happens to the 
granules during exocytosis and whether the signalling pathways are 
located on the granules or on the cellular plasma membranes.
As stated earlier, mastoparan stimulates exocytosis in a wide 
variety of cells. According to Gil et al. (1991) the early events 
in mastoparan1s actions include the breakdown of phosphoinositides 
and the mobilization of Ca2+ from intracellular stores. Gil et al. 
(1991) also suggest that these signaling pathways are activated by
direct activation of G-proteins, by passing the membrane receptors. 
In fact, mastoparan behaves much like the activated membrane 
receptors in activating G-proteins (Higashijima et al. 1988). This 
implies that the effects of mastoparan should be blocked by 
pertussis toxin, which ADP ribosylates and functionally deactivates 
G-proteins. This was found to be true by Aridor et al. (1990) and 
Higashi jima et al. (1988) when they discovered that pertusis toxin 
inhibits the mastoparan promoted histamine release in mast cells by 
over 80%. On the other hand pertussis toxin did not inhibit 
histamine secretion induced by the Ca2+ ionophore A23187 in mast
cells. This indicates that mastoparan acts either before or at the 
G-protein that activates phospholipase C while the calcium 
ionophore acts at a step beyond the release of IP3. Furthermore, 
according to Rubins et al., mastoparan preferentially activates Gt 
over Gs and it has been shown to interact with the Gia terminal to 
activate the G-protein.
However, mastoparan may affect other cellular activities 
besides the activation of G-proteins, such as the direct activation 
of phospholipases A2 and C. This was suggested by Rubins et al. 
when they studied the effects of mastoparan on secretion of 
surfactant by Type 2 alveolar cells. This system does not have a 
secretion pathway controlled by G±. Mastoparan led to an 8-fold 
increase in secretion of surfactant from these cells and this 
secretion was not affected by pertussis toxin. According to Rubins 
et al. there were three possible solutions to this puzzle; one, 
incomplete ribosylation of pertussis toxin substrates; two,
mastoparan*s intrinsic ability to activate G-proteins despite ADP 
ribosylation? or three, the presence of non-pertusis toxin 
sensitive secretion pathways in type 2 alveolar cells. The 
mastoparan induced rise in IP3 apparently shows that it is not 
under the control of pertussis toxin, in that it did not completely 
abolish the rise in IP3 levels. A possible explanation for this 
being the continued activity of the G-protein even after ADP 
ribosylation by the toxin. Pertussis toxin also had minimal effect 
on mastoparan induced arachidonic acid release indicating that 
there are pathways that are pertussis toxin insensitive and 
subsequently not controlled by G-protein. Since arachidonic acid is 
produced by the action of PL-A2 on membrane phospholipids, this
also leads us to conclude that phospholipase A2 is not controlled 
by a G-protein, or it is controlled by a G-protein not susceptible 
to pertussis toxin.
Procedure
1) Isolation Procedure for Pancreatic Zymogen Granules.
Zymogen Granules were isolated from male Sprague-Dawley rats 
(150-3OOg) by methods described by Gasser et al. (1988). The 
pancreas was extracted and placed in ice cold homogenization buffer 
(250 mM sucrose, 50 mM 3-(N-morpholino) propane sulfonic acid 
(MOPS) (pH 7.0 with NaOH), O.lmM MgSO^ 0.1 mM ethylene glycol-bis 
(B-aminoethyl ether) -N, N*, N '-tetracetic acid (EGTA) (free Ca2+ 
10"7M), lmg/mL fatty acid free bovine serum albumin and 0.2 mM 
phenylmethyl sulfonyl fluoride (PMSF). The pancreas was minced to
a fine paste using a glass-teflon homogenizer at 500 rpm. This 
crude homogenate was subjected to 750 psi by nitrogen cavitation. 
The cavitation served to disrupt most of the intact cells and 
released intact zymogen granules. A percoll buffer was added to the 
homogenate to give final concentrations of 250 mM sucrose, 40% 
Percoll, 50 mM 2-(N-morpholino) ethanesulfonic acid (pH 6.5 with 
NaOH), 25 mM MOPS, 2.0 mM EGTA, 2.0 mM MgS04, 1 mg/mL BSA, and 0.2
mM PMSF. The homogenate was centrifuged at 20,000g for 20 minutes. 
The granules being dense formed a distinct band towards the bottom 
of the gradient.
2. Isolation Procedure for Plasma Membranes.
The density gradient formed in the isolation of zymogen 
granules also yielded a low density fraction rich in plasma 
membranes. The plasma membranes were further purified by diluting 
this fraction in a solution containing 250 mM sucrose, 40 mM MOPS 
(ph 7.0 with NaOH), 0.1 mM EGTA, and 0.1 mM MgS04. This solution 
was centrifuged at 2000g. The pellet was discarded and the 
supernatant was centrifuged at 30000g. This time the supernatant 
was discarded and the pellet was resuspended in the buffer 
described above. This suspension was used as the plasma membrane 
fraction for the membrane fusion experiments.
3. Measurement of Chloride Transport.
Conventional ion transport techniques cannot be used with 
zymogen granules because of their mechanical fragility therefore 
light scatter techniques were used to measure chloride transport 
across zymogen granule membranes. This method is explained by 
Gasser et.al and it involves measuring chloride transport by the
rate of granular swelling and lysis. This is determined by 
following the changes in the optical density ( OD 540 nm) of the 
granule suspension.
The granules were suspended in a KC1 light scatter solution 
which contains 150 mM KC1, 1.0 mM EGTA, 0.1 mM MgSO^ 20 mM N-2- 
hydroxyethylethylpiperazine-N’-2-ethanesulfonic acid (HEPES) (pH 
7.0 with KOH). The granule membrane was artificially permeabilized 
by inserting the potassium ionophore valinomycin. Chloride follows 
the cation movement and is transported into the granular lumen 
through the endogenous channels. Fluid follows solute accumulation 
in the granular lumen and causes swelling and lysis of the 
granules. Therefore granule lysis is directly dependant upon 
chloride transport. Granule lysis can be followed by time dependant 
changes in the optical density of the granule suspension at 37°C 
and 540 nm. The changes in optical density are measured using a DU- 
64 spectrophotometer and a Beckman data capture system.
4. Measurement of Rate of Membrane Fusion
The fusion of plasma membrane to zymogen granule membrane was 
studied in this experiment. Zymogen granules and plasma membranes 
were suspended in KC1 light scatter solution which contains 150 mM 
KCl, 1.0 mM EGTA, 0.1 mM MgSO^ 20 mM N-2-hydroxyethylmethyl 
piperazine-N'-2-ethanesulfonic acid (HEPES) (pH 7.0 with KOH). The 
fusion of the two membranes causes changes in the optical density 
of the suspension at wavelength 540 nm. These changes were measured 
using a DU-64 spectrophotometer and Beckman data capture system. 
The fusion samples were maintained at 37°C. The effect of
mastoparan on fusion capacity was tested by pretreatment of the 
membrane with various concentrations of the toxin.
Controls were run with zymogen granules or the plasma 
membranes alone in the KC1 light scatter solution to determine the 
fraction of the signal not attributable to the fusion.
Results
The ability of the secretory vesicles isolated from the 
pancreas, to transport Cl~ across the membrane and to fuse with the 
cellular plasma membranes is illustrated in Figure 1. The two 
physiological events are critical steps in the exocytotic release 
of macromolecular products from exocrine, endocrine and neuronal 
cells. The venom mastoparan is known to stimulate exocytotic 
secretion in many cells. To ascertain the mechanism of mastoparan 
action, its effect on vesicle transport and fusion capabilities was 
determined.
High concentrations of mastoparan (> 0.025 uM) caused the non­
specific lysis of secretory vesicles. Lower concentrations (< 0.5 
uM) did not alter the Cl“ transport across the vesicle membrane, 
nor was a response evident if Ca2+ () or GTP () was included with 
the mastoparan (Table 1). Although vesicle swelling, a process 
mediated by Cl“ transport, is thought to be a necessary component 
of exocytosis, the data suggests that mastoparan does not act by 
increasing the efficiency of the transport event.
Membrane fusion is a function of a number of factors. Membrane 
fusion was monitored in the presence or absence of mastoparan. 
Mastoparan alone had an insignificant effect on fusion rate (Table
2). However mastoparan in the presence of 6TP (1 mM) stimulated 
fusion by approximately 2-fold. Furthermore, GTP in the absence of 
mastoparan had no effect.
Discussion
It was noticed throughout the experiments that high- 
concentration of mastoparan causes non-specific lysis of the 
granules in a dose dependant manner. The rate of lysis became 
faster as the concentration of mastoparan was increased. At very 
high concentrations the granules lysed instantaneously after 
contact with mastoparan, demonstrating the destructive effect of 
mastoparan on membranes. There are two possible explanations for 
this, one, mastoparan has the ability to destroy membranes which is 
how it gets inside plasma membranes and influences G-proteins 
directly? and two its activation of G-proteins dependent 
phospholipases (present in granule membranes) which rapidly 
hydrolyze membrane phospholipids. High concentration of mastoparan 
causes activation of all these phospholipases present in the 
membrane which subsequently destroys it causing granule lysis. 
Higashijima et al. (1988) have proposed that mastoparan, being an 
amphiphilic cation, may be able to cross the plasma membrane in 
response to membrane potential where it can affect G-proteins 
directly. A similar mechanism is possible for our observation that 
mastoparan causes granule lysis at high concentration. This ability 
of mastoparan to cross plasma membranes in response to membrane 
potential makes it an important tool in the study of exocytosis and 
secretion.
Chloride transport across the granule membrane was not 
affected by mastoparan. Increased concentrations of mastoparan did 
not affect the secretagogue activated Cl" transport across granule
membrane. According to Gasser et al. (1990) Cl" transport across 
granule membrane is regulated by two pathways, one which involves 
release of Ca2+ from intracellular stores by the breakdown of 
phosphatidylinositol bisphosphate and the activation of protein 
Kinase C by the high Ca2+ levels. The other pathway that appears to 
regulate chloride transport is the activation of adenylate cyclase 
and elevation of cAMP levels which activates protein kinase A and 
subsequently chloride transport. The reason Cl" is not affected is 
because calcium is not present to activate the protein kinase C 
even if the breakdown of phosphatidyl inositide does occur and in 
the second case the absence of ATP on granule membranes prevents 
any cAMP formation even though adenylate cyclase is probably 
activated by mastoparan. However, what the present results 
demonstrate is that an endogenous G-protein is not associated with 
the secretory granule that has a direct influence on the 
electrolyte permeability.
Vesicle to apical membrane fusion was stimulated by mastoparan 
in the presence of GTP, however GTP alone did not promote fusion 
and fusion did not exhibit dose dependance to GTP. According to 
Higashijima et al. (1988) mastoparan stimulated the dissociation of 
GDP from a G-protein thus stimulating the association of GTP to the 
G-protein. The highest binding rate observed by Higashijima et al. 
(1988) was Kobs~2/min. which is comparable to the rate observed for
receptor stimulated G-proteins.
Fusion is stimulated by increased fluidity of the membrane 
and one way membrane fluidity is increased is by the action of PL- 
A2 on membranes. According to Rubin et al. action of PL-A2 causes
the breakdown of membrane phospholipids and causes the formation of 
lysophospholipids and arachidonic acid which led to an increase in 
membrane fluidity and stimulate fusion. In a recent study Rubin et 
al. (1991) have provided evidence that PL-A2 is present in zymogen 
granule membranes and is regulated by G-proteins by a mechanism 
that is not yet known. Activation of these G-proteins by 
mastoparan, much like a receptor does and the subsequent activation 
of PL-A2 might be a reason that mastoparan stimulates fusion.
Mastoparan needs GTP to stimulate fusion also points to the fact 
that G-proteins present on the granule membrane are controlling 
this important physiological function.
Here, we propose a model for in vivo fusion of zymogen 
granules to plasma membranes based on the data we have gathered in 
our project and some other studies conducted in the past.
Mastoparan passes through the cellular plasma membrane because 
of its amphiphilic properties and the resting membrane potential. 
In the cytosol, it comes in contact with zymogen granules where it 
activates G-proteins associated with PL-A2. PL-A2 causes the 
formation of lysophospholipids and arachidonic acid, both of which 
have long been considered potential mediators of fusion. The 
accumulation of lysophospholipids and arachidonic acid increases 
membrane fluidity (Rubin et al. 1991). This causes fusion of 
zymogen granules to plasma membrane. In addition the change in
fluidity can also directly promote an increase in the Cl- transport 
by the zymogen granule, as has been shown by Gasser et al. (1990). 
This in conjunction with the activation of adenylate cyclase and 
protein kinase A causes an influx of Cl- and swelling by the 
granule.
Our model proposes that the sensitive control for initiation 
of exocytosis is at the granule itself and not at the plasma 
membrane as has been proposed earlier. It also proposes that there 
is evidence that PL-A2 is controlled by G-proteins and 
present on the zymogen granule membrane.
it is
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Table 1 The effect of mastoparan on the rate of 








0 0.6 + 0.2 2.4 + 0.4
0.01 0.7 ± 0.1 2.3 ± 0.7
0.025 1.3 ± 0.5 2.0 ± 0.8
0.05 2.3 + 0.8 2.9 + 1.8
0.075 3.3 ± 1.3 4.2 ± 1.9
0 . 1 4.7 ± 0.9 4.3 ± 1.8
Results are based on 5 separate zymogen granule preparations 
and are expressed as the mean + standard error.
Table 2. The effect of mastoparan on the 
ability of pancreatic secretory 




Control 1.39 ± 0.6





1 mM GTP 
(0 Mastoparan)
1.80 ± 0.5
The mastoparan concentration was 0.025 uM. 
All experiments represent the mean + SE 
for 5 membrane preparations.
Figure l. (Left Panel) The demonstration of Cl” transport 
by zymogen granules. At the arrow, valinomycin (10 ug/ml) 
was added to the granules suspended in 150 mM KCl, pH 7.0,
^  at 37°C. Valinomycin causes an influx of potassium and
serves as the driving force for Cl” transport through the 
endogenous granule Cl” channels. This accumulation of 
solute causes the granules to swell and lyse (decrease in 
optical density).
^  (Right Panel) The demonstration of membrane
fusion between zymogen granules and pancreatic apical 
membrane in vitro. The upper trace (ZG) represents the 
zymogen granules alone, and the lower trace (ZG + PM) 
represents zymogen granules plus apical plasma membrane. As 
, the membranes fuse, the granule core solubilizes and the
*  optical density decreases.
